Jean-François Leprince – Managing Partner
Mr. Jean-Francois Leprince comes to the fund from his position as President and CEO of Aventis Pharma Canada. Mr. Leprince previously served in several management positions in Europe, the Middle East, Africa and France with Marion Merrell Dow, the pharmaceutical subsidiary of The Dow Chemical Company as well as with Hoechst Marion Roussel the pharmaceutical subsidiary of the Hoechst Group.
Mr. Leprince brings over 30 years of experience with large pharmaceutical companies to the table along with first hand knowledge of overseeing the largest R&D spend of any of the multinational pharmaceutical companies operating in Canada. Mr. Leprince also brings valuable practical experience on the operational perspectives of overseeing new products through development to market; and the financial wherewithal to accomplish this.